For the year ending 2025-12-31, BIOF had $16,403 increase in cash & cash equivalents over the period. -$913,900 in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) | -2,874,601 |
| Depreciation and amortization | 145,852 |
| Stock based compensation | 1,020,478 |
| Issuance of warrants for interest expense | 24,477 |
| Prepaid expenses | -20,938 |
| Accounts payable | -66,092 |
| Accounts payable - related party | -24,100 |
| Deferred wages and directors fees - related party | 917,265 |
| Interest payable - related party | -9,219 |
| Net cash used in operating activities | -845,002 |
| Purchase of property and equipment | 68,898 |
| Payment of deposits on property | 50,000 |
| Additions to patent and trademark costs | 18,447 |
| Net cash from (used in) investing activities | -137,345 |
| Proceeds from issuance of common stock | 745,000 |
| Proceeds from the issuance of convertible notes - rp | 185,000 |
| Proceeds from exercise of warrants | 68,750 |
| Net cash provided by financing activities | 998,750 |
| Net increase (decrease) in cash and cash equivalents | 16,403 |
| Cash and cash equivalent at beginning of the year | 48,797 |
| Cash and cash equivalent at end of the year | 65,200 |
BLUE BIOFUELS, INC. (BIOF)
BLUE BIOFUELS, INC. (BIOF)